תוכנית מדעית

15:00-15:30: התכנסות ורישום, כיבוד קל

15:30-15:35 : פתיחה וברכות, פרופ' רון שאול, יו"ר האיגוד.

15:35-15:50: הצגות קצרות של המחקרים זוכי מלגות האיגוד (5 דקות כ"א).

15:50-16:00: מילים לזכרו של ד"ר עקיבא פרדקין ז"ל, ד"ר בתיה וייס.

16:00-17:00: מושב ראשון, מחלות מעי דלקתיות. יו"ר-ד"ר אורן לדר, ד"ר ברוך  ירושלמי

                             (הזמנים המופיעים כוללים 2 דקות לשאלות).

16:00-16:12, Pediatric IBD epidemiology in Israel and the burden of perianal Crohn's disease: an update from the epi-IIRN study.

Mira Stulman and Ohad Atia, Shaare Zedek Medical Center.

16:12-16:24, Outcomes in the era of biologics and the rate of lymphoma in pediatric patients with IBD: A population-based study from the epi-IIRN database.

Dan Turner, Shaare Zedek Medical Center

16:24-16:34, Clock gene expression levels can differentially distinguish between Ulcerative Colitis and Crohn’s disease.

Yael Weintraub, Tel Aviv Medical Center.

16:34-16:42, Positivity of stool sampling for enteric pathogens during inflammatory bowel disease flares in pediatric patients and its impact on disease outcomes.

Pesach Melnik, Schneider Children's Medical Center.

16:42-16:50, Increased risk of anti-drug antibodies to the second anti-tumor necrosis factor alpha in patients who developed antibodies to a first drug from the same class.

Amit Assa, Schneider Children's Medical Center.

16:50-17:00, Characterization of T cell receptor repertoire patterns of circulating α4β7 positive memory T cells in ulcerative colitis.

Adir Gamliel, Sheba Medical Center.

17:00-17:30: הרצאת מרצה אורח 

State of the art lecture: Probiotics for functional gastrointestinal disorders.

What is the evidence in 2020? Prof. Hania Szajewska. The Medical University of Warsaw.

17:30-18:00: הפסקה.

18:00-19:00: מושב שני, צליאק. יו"ר- ד"ר ענת גוז-מרק, ד"ר חני טאף אוליבסטון 

                               (10 דקות לכל מצגת: 8 דקות להצגה, 2 דקות לשאלות).

18:00-18:10, Endomysial Antibodies Positivity Among Children and Adolescents with High Positive Anti-Tissue Transglutaminase Type 2 Iga Antibodies.

Amir Ben-Tov, Tel Aviv Medical Center.

18:10-18:20, Very Low Birth Weight Preterm Infants have Decreased Celiac Disease Autoimmunity During Childhood and Adolescence.

Amir Ben-Tov, Tel Aviv Medical Center.

18:20-18:30, Defining the Celiac Disease Transcriptome using Clinical Pathology Specimens Reveals Biologic Pathways and Supports Diagnosis.

Yael Haberman, Sheba Medical Center.

18:30-18:40, The real-life performance of the Bioplex 2200 celiac serology test during a one-year period. Michal Kori, Kaplan Medical Center.

18:40-18:50, The prevalence of overweight in newly diagnosed children with celiac disease is equivalent to underweight, and does not change significantly under gluten-free diet.

Adi Anafy, Tel Aviv Medical Center.

18:50-19:00, Age-dependent trends of paediatric coeliac disease - a tertiary center experience. Alex Krauthammer, Schneider Children's Medical Center.

19:00-19:30: הרצאת מרצה אורח

State of the art lecture: Advances in the management of infantile colic.

Prof. Hania Szajewska. The Medical University of Warsaw.

8:00-9:00: מושב שלישי, נושאים שונים בגסטרואנטרולוגיה. יו"ר- ד"ר צילי צנגן, פרופ' אפרת ברוידא

                    (10 דקות לכל מצגת: 8 דקות להצגה, 2 דקות לשאלות).

8:00-8:10, Systemic Steroids Have a Role in the Treatment of Moderate to Severe Esophageal Strictures in Pediatric Eosinophilic Esophagitis.

Assaf Hoofien, Schneider Children's Medical Center.

8:10-8:20, The characteristics of pediatric eosinophilic esophagitis in Northern Israel.

Irit Rozen, Rambam Medical Center.

8:20-8:30, A Novel Nutritional Approach to Infants and Children with Congenital Diarrhea due to Homozygous DGAT1 Mutations.

Peri Millman, Hadassah Medical Center.

8:30-8:40, Maturation of the Human Intestinal Immune System Occurs Early in Fetal Development. Dror Shouval, Sheba Medical Center.

8:40-8:50, Ileo-colonoscopy versus sigmoidoscopy in the evaluation of gastrointestinal symptoms in pediatric patients post hematopoietic-cell transplantation.

Mordechai Slae, Hadassah Medical Center.

8:50-9:00, Sharp Foreign Bodies May Pass Spontaneously Through Gastrointestinal Tract Without Harmful Side Effects.

Hussein Shamaly, French Hospital, Nazareth.

9:00-9:30: הרצאת מרצה אורח: הקשר בין מיקרוביוטה לתחלואה. What is the evidence?

ד"ר נעמה גבע-זטורסקי, הטכניון, חיפה

9:30-10:00: הפסקה

10:00-11:00: מושב רביעי, מחלות כבד. יו"ר- ד"ר מיכל בר-לב, ד"ר שלומי כהן

      (10 דקות לכל מצגת: 8 דקות להצגה, 2 דקות לשאלות).

10:00-10:10, Bile duct recovery in a toxic model of biliary atresia using L-NAC,
IL-33, and IL-13.

Tal Cozacov, Schneider Children's Medical Center.

10:10-10:20, In-vivo mouse model of biliary atresia: A genetic-environmental combined approach. Rachel Frenklak, Schneider Children's Medical Center.

10:20-10:30, The Natural History of children with IBD & Associated Liver Disease-
A National Multi-Center Study.

Achiya Amir, Tel Aviv Medical Center.

10:30-10:40, How far should we go evaluating abnormal isolated aminotransferase levels in children.

Ramit Magen-Rimon, Rambam Medical Center.

10:40-10:50, Outcome of Kasai Portoenterostomy Based on Ductal Diameter at Porta Hepatis.

Michael Shpoliansky, Schneider Children's Medical Center.

10:50-11:00, Characterization and Natural History of Congenital Intrahepatic Porto-Systemic Shunts. Eyal Shteyer, Shaare Zedek Medical Center.

11:00-11:30: הרצאת מרצה אורח: מיקרוביום כיעד טיפולי- הווה ועתיד. ד"ר אילן יונגסטר, בית החולים ע"ש שמיר, צריפין.

11:30-11:45: הפסקה קצרה

11:45-12:45: מושב חמישי, מחלות מעי דלקתיות. יו"ר- ד"ר אבישי להד, ד"ר ורד פינסק

                    (10 דקות לכל מצגת: 8 דקות להצגה, 2 דקות לשאלות).

11:45-11:55, Milk derived exosomes has a therapeutic effect on experimental colitis.

Shimon Reif, Hadassah Medical Center.

11:55-12:05, Sarcopenia is a predictor for severe disease course in pediatric Inflammatory Bowel Disease. Anat Yerushalmy-Feler, Tel Aviv Medical Center.

12:05-12:15, Combination therapy of adalimumab with an immunomodulator is not more effective than adalimumab monotherapy in children with Crohn's disease: A post-hoc analysis of the PAILOT randomized control trial.

Manar Matar Schneider Children's Medical Center.

12:15-12:25, Therapeutic drug monitoring increases drug retention of anti-tumor necrosis factor alpha agents in pediatric patients with Crohn's disease.

Yoel Gofin, Schneider Children's Medical Center.

12:25-12:35, Fecal calprotectin and drug levels at week 14 predict long-term response of Vedolizumab in paediatric inflammatory bowel diseases: a report from the prospective, multi-centre VEDOKIDS study. Zivia Shavit-Brunschwig, Shaare Zedek Medical Center.

12:35-12:45, The effect of Adalimumab on linear growth in children with Crohn's disease: A post-hoc analysis of the PAILOT randomized control trial.

Manar Matar, Schneider Children's Medical Center.

12:45-13:25: הרצאת מרצה אורח: קנביס למטרות רפואיות- " מחומר אסור לתרופה מבטיחה "

                     ד"ר מיכאל דור.

13:25-13:30: תודות ועדכוני ועד האיגוד.